Brief: Sellas Provides Corporate Updates, Highlights Upcoming Milestones

Sellas Life Sciences

03/01/2024 12:45

Jan 3 (Reuters) - Sellas Life Sciences Group Inc
 SLS.O :
    * SELLAS PROVIDES CORPORATE UPDATES AND HIGHLIGHTS KEY
UPCOMING
MILESTONES
    * INTERIM ANALYSIS OF PHASE 3 REGAL STUDY OF GALINPEPIMUT-S
IN
PATIENTS WITH ACUTE MYELOID LEUKEMIA EXPECTED IN Q1 2024
    * PHASE 2A STUDY OF SLS009 IN RELAPSED/REFRACTORY AML
PATIENTS
ONGOING WITH TOPLINE DATA EXPECTED IN Q1 OF 2024
    * PHASE 1B/2 STUDY IN RELAPSED/REFRACTORY PERIPHERAL T-CELL
LYMPHOMA PATIENTS ONGOING WITH TOP-LINE DATA EXPECTED IN H1 2024

Source text for Eikon:  ID:nGNX281r9x 
Further company coverage:  SLS.O 

 ((Reuters.Briefs@thomsonreuters.com;))